1. Cancer therapy using tumor-associated antigens to reduce side effects

   • David Siu

   Review Article 01 May 2009 Pages: 181 - 198

   

2. Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model

   • M. A. Pantaleo
   • L. Landuzzi
   • G. Biasco

   Original Article Open access 19 February 2009 Pages: 199 - 205

   

3. Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma

   • Hai-Yan Zhang
   • Xin Meng
   • Wei-Wei Deng

   Original Article 10 February 2009 Pages: 207 - 213

   

4. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis

   • Xue-Ting Shao
   • Lei Feng
   • Hang-Ping Yao

   Original Article 19 February 2009 Pages: 215 - 221

   

5. Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis

   • Norma Torres-Carrillo
   • Nora Magdalena Torres-Carrillo
   • José Francisco Muñoz-Valle

   Original Article 24 February 2009 Pages: 223 - 228

   

6. Antifibrotic effect of edaravone in rat liver cirrhosis induced by dimethylnitrosamine

   • Hiroto Tanaka
   • Hiroki Ueda
   • Masakazu Ichinose

   Original Article 04 March 2009 Pages: 229 - 233

   

7. Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis

   • Yildiz Oner-Iyidogan
   • Pernur Oner
   • Aydin Turkmen

   Original Article 24 February 2009 Pages: 235 - 241

   

8. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile

   • Michela Zanetti
   • Alessandra Bosutti
   • Rocco Barazzoni

   Original Article 24 February 2009 Pages: 243 - 248

   

9. Duffy genotyping facilitates transfusion therapy

   • Carlos Cotorruelo
   • Claudia Biondi
   • Amelia Racca

   Short Communication 19 February 2009 Pages: 249 - 251